Increasing compliance with a clinical practice guideline for fetal fibronectin testing and the management of threatened preterm labour: A quality improvement project.

<bold>Objective: </bold>To increase adherence to a local hospital clinical practice guideline for the use of fetal fibronectin testing in women presenting with symptoms of threatened preterm labour.<bold>Study Design: </bold>A quality improvement project using a multi-faceted implementation strategy.<bold>Setting: </bold>National Women's Health, Auckland City Hospital; a tertiary referral maternity unit in Auckland, New Zealand.<bold>Population: </bold>All obstetricians, junior obstetric doctors and hospital employed midwives.<bold>Methods: </bold>A pre-education audit and survey, compulsory interactive educational intervention with audit feedback and provision of reminders followed by a post-education audit and survey one year later.<bold>Main Outcome Measures: </bold>Number of fetal fibronectin tests performed, proportion of tests performed meeting clinical criteria for testing and proportion of results managed according to hospital guideline.<bold>Results: </bold>There was a 25% increase in the number of tests performed with an increase in the proportion that met clinical criteria for testing, 76% (31/41)-93% (51/55) (OR 4.1, 95% CI 1.2-14.2). Adherence to guidelines for clinical management according to fFN results changed over time, 80% (33/41)-95% (52/55) (OR 4.2, 95% CI 1.04-17.0). Clinician knowledge on some (but not all) indications for fFN testing improved. Education and reminders did not improve understanding of clinical scenarios that may result in a false positive fFN test.<bold>Conclusions: </bold>A multi-faceted approach of audit and clinician feedback, interactive education and reminders supports the implementation of a clinical practice guideline for the use of fFN as a preterm birth prediction test for women presenting with symptoms of threatened preterm labour. [ABSTRACT FROM AUTHOR]